Common acne medication, minocycline, offers new treatment for multiple sclerosis

 "A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.

In addition to being an unexpected discovery - an acne drug benefitting a neurological disorder - the discovery is significant as it offers a safe and affordable treatment option for those with early onset MS. This discovery could impact thousands of newly diagnosed MS patients around the world."

Here's the paper

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis New England Journal of medicine 

'via Blog this'

No comments: